These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 70921)

  • 1. Metabolism of 5-S-cyteinyldopa by O-methylation.
    Agrup G; Falck B; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(4):309-12. PubMed ID: 70921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism.
    Stramentinoli G; Di Padova C; Gualano M; Rovagnati P; Galli-Kienle M
    Gastroenterology; 1981 Jan; 80(1):154-8. PubMed ID: 7450400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
    Graef V; Paul E
    Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O- and S-methylated bromothiocatechols.
    Lertratanangkoon K
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):200-7. PubMed ID: 8212002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonintracellular, cell-associated O-methylation of isoproterenol in the isolated rabbit thoracic aorta.
    Head RJ; Irvine RJ; Barone S; Stitzel RE; de la Lande IS
    J Pharmacol Exp Ther; 1985 Jul; 234(1):184-9. PubMed ID: 4009500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S; Wakamatsu K; Inoue S; Fujita K
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 5-S-glutathionyldopa.
    Carstam R; Edner C; Hansson C; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol Suppl (Stockh); 1986; 126():1-12. PubMed ID: 3103358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA methylation by S-adenosylethionine with the production of methyl-deficient DNA in regenerating rat liver.
    Cox R; Irving CC
    Cancer Res; 1977 Jan; 37(1):222-5. PubMed ID: 830409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(4):355-6. PubMed ID: 92151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and metabolism of tritiumlabelled 5-S-cysteinyldopa in mice.
    Ito S; Teradaira R; Fujita K
    Biochem Pharmacol; 1980 Dec; 29(24):3277-80. PubMed ID: 6783047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methylation and degradation of chromatin DNA in isolated rat liver cell nuclei].
    Khodarev NN; Votrin II; Sokolov NN; Basnak'ian AG
    Biokhimiia; 1979 Jun; 44(6):1058-67. PubMed ID: 465603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E; Graef V; Ruppel R; Hellwich M
    Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
    Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro o-methylation of 1-(3,4-dihydroxyphenyl)-2-(n-propyl-amino) propane - an intermediate in N-(N-propyl) amphetamine metabolism.
    Coutts RT; Jones GR
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):173-6. PubMed ID: 7079586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues.
    Morishima T; Tatsumi F; Fukada E; Watanabe M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(5):329-33. PubMed ID: 6419680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.